Search Results Search Sort by RelevanceMost Recent Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019; 21(11):E936-942. doi: 10.1001/amajethics.2019.936. Policy Forum Nov 2019 Why Quality-of-Life Data Collection and Use Should Be Standardized When Evaluating Candidates for Hand Transplantation Martin Kumnig, PhD, MSc, Emma K. Massey, PhD, and Lisa S. Parker, PhD Improving candidate evaluation and informed consent is key to motivating authenticity, not just voluntariness. AMA J Ethics. 2019; 21(11):E974-979. doi: 10.1001/amajethics.2019.974. Case and Commentary Feb 2019 How Should Clinicians Communicate With Patients About the Roles of Artificially Intelligent Team Members? Daniel Schiff, MS and Jason Borenstein, PhD Clinical applications of AI prompt consideration of how responsibility should be distributed among professionals, tech companies, and others. AMA J Ethics. 2019; 21(2):E138-145. doi: 10.1001/amajethics.2019.138. Policy Forum Feb 2019 What Are Important Ethical Implications of Using Facial Recognition Technology in Health Care? Nicole Martinez-Martin, JD, PhD Applications can identify and monitor patients. They can also diagnose genetic, medical, and behavioral conditions. AMA J Ethics. 2019; 21(2):E180-187. doi: 10.1001/amajethics.2019.180. Case and Commentary Feb 2020 How Should Vaccine Campaigns Balance Need for Clear Communication Against Need for Timely Administration of Large-Scale Programs? Paul Ndebele, PhD and Sithembile Ruzario, MSc Limited understanding of disease etiology often leads to resistance, which can result in low vaccine uptake. AMA J Ethics. 2020; 22(2):E76-81. doi: 10.1001/amajethics.2020.76. Case and Commentary Feb 2016 Should Physicians Attempt to Persuade a Patient to Accept a Compromised Organ for Transplant? Andy A. Tully, MD, Geraldine C. Diaz, DO, and John F. Renz, MD, PhD Transplant physicians must respect indecisive patients’ autonomy while continuing to educate them during their progress towards transplantation. AMA J Ethics. 2016; 18(2):101-107. doi: 10.1001/journalofethics.2017.18.2.ecas1-1602. Policy Forum Mar 2016 Medical Malpractice Reform: Historical Approaches, Alternative Models, and Communication and Resolution Programs Joseph S. Kass, MD, JD and Rachel V. Rose, JD, MBA Alternatives to suing could help open communication between injured patients and clinicians. AMA J Ethics. 2016; 18(3):299-310. doi: 10.1001/journalofethics.2016.18.3.pfor6-1603. Case and Commentary Jan 2016 Should Children be Asked to be Bone Marrow Donors for Siblings? Katrina Ann Williamson and Christian J. Vercler, MD, MA A patient- and family-centered approach can illuminate possible risks and benefits of bone marrow donation to child donors and sibling recipients. AMA J Ethics. 2016; 18(1):18-23. doi: 10.1001/journalofethics.2017.18.1.ecas3-1601. Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022; 24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063. Policy Forum Nov 2022 Necessity for and Limitations of Price Transparency in American Health Care Harold A. Pollack, PhD, MPP More transparent pricing would allow patients and families to make better decisions, but there are limitations to how reliably it promotes efficiency and market discipline. AMA J Ethics. 2022; 24(11):E1069-1074. doi: 10.1001/amajethics.2022.1069. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019; 21(11):E936-942. doi: 10.1001/amajethics.2019.936.
Policy Forum Nov 2019 Why Quality-of-Life Data Collection and Use Should Be Standardized When Evaluating Candidates for Hand Transplantation Martin Kumnig, PhD, MSc, Emma K. Massey, PhD, and Lisa S. Parker, PhD Improving candidate evaluation and informed consent is key to motivating authenticity, not just voluntariness. AMA J Ethics. 2019; 21(11):E974-979. doi: 10.1001/amajethics.2019.974.
Case and Commentary Feb 2019 How Should Clinicians Communicate With Patients About the Roles of Artificially Intelligent Team Members? Daniel Schiff, MS and Jason Borenstein, PhD Clinical applications of AI prompt consideration of how responsibility should be distributed among professionals, tech companies, and others. AMA J Ethics. 2019; 21(2):E138-145. doi: 10.1001/amajethics.2019.138.
Policy Forum Feb 2019 What Are Important Ethical Implications of Using Facial Recognition Technology in Health Care? Nicole Martinez-Martin, JD, PhD Applications can identify and monitor patients. They can also diagnose genetic, medical, and behavioral conditions. AMA J Ethics. 2019; 21(2):E180-187. doi: 10.1001/amajethics.2019.180.
Case and Commentary Feb 2020 How Should Vaccine Campaigns Balance Need for Clear Communication Against Need for Timely Administration of Large-Scale Programs? Paul Ndebele, PhD and Sithembile Ruzario, MSc Limited understanding of disease etiology often leads to resistance, which can result in low vaccine uptake. AMA J Ethics. 2020; 22(2):E76-81. doi: 10.1001/amajethics.2020.76.
Case and Commentary Feb 2016 Should Physicians Attempt to Persuade a Patient to Accept a Compromised Organ for Transplant? Andy A. Tully, MD, Geraldine C. Diaz, DO, and John F. Renz, MD, PhD Transplant physicians must respect indecisive patients’ autonomy while continuing to educate them during their progress towards transplantation. AMA J Ethics. 2016; 18(2):101-107. doi: 10.1001/journalofethics.2017.18.2.ecas1-1602.
Policy Forum Mar 2016 Medical Malpractice Reform: Historical Approaches, Alternative Models, and Communication and Resolution Programs Joseph S. Kass, MD, JD and Rachel V. Rose, JD, MBA Alternatives to suing could help open communication between injured patients and clinicians. AMA J Ethics. 2016; 18(3):299-310. doi: 10.1001/journalofethics.2016.18.3.pfor6-1603.
Case and Commentary Jan 2016 Should Children be Asked to be Bone Marrow Donors for Siblings? Katrina Ann Williamson and Christian J. Vercler, MD, MA A patient- and family-centered approach can illuminate possible risks and benefits of bone marrow donation to child donors and sibling recipients. AMA J Ethics. 2016; 18(1):18-23. doi: 10.1001/journalofethics.2017.18.1.ecas3-1601.
Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022; 24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063.
Policy Forum Nov 2022 Necessity for and Limitations of Price Transparency in American Health Care Harold A. Pollack, PhD, MPP More transparent pricing would allow patients and families to make better decisions, but there are limitations to how reliably it promotes efficiency and market discipline. AMA J Ethics. 2022; 24(11):E1069-1074. doi: 10.1001/amajethics.2022.1069.
